Current views of the risk of stroke for migraine with and migraine without aura

Current Pain and Headache Reports

Volumn 10, Issue 3, 2006, Pages 214-220

  Kurth, Tobias ^a   Diener, Hans Christoph ^b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ACETYLSALICYLIC ACID PLUS DIPYRIDAMOLE; ANTIMIGRAINE AGENT; BLOOD CLOTTING FACTOR 5 LEIDEN; ORAL CONTRACEPTIVE AGENT; PROTHROMBIN; VON WILLEBRAND FACTOR;

ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CHROMOSOME MAP; CONGENITAL HEART DISEASE; DISEASE ASSOCIATION; GENETIC LINKAGE; GROUPS BY AGE; HUMAN; MIGRAINE WITH AURA; MIGRAINE WITHOUT AURA; MOLECULAR MECHANICS; MULTIVARIATE ANALYSIS; MUTATIONAL ANALYSIS; OBSERVATIONAL STUDY; PATHOPHYSIOLOGY; PREVALENCE; SEX DIFFERENCE; VASCULAR LESION;

HUMANS; MIGRAINE WITH AURA; MIGRAINE WITHOUT AURA; RISK FACTORS; STROKE;

EID: 33745316970     PISSN: 15313433     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11916-006-0048-5     Document Type: Article

References (60)

1. Goadsby PJ: Neurovascular headache and a midbrain vascular malformation: evidence for a role of the brain-stem in chronic migraine. Cephalalgia 2002, 22:107-111.
2. Silberstein SD: Migraine. Lancet 2004, 363:381-391.
3. Lipton RB, Bigal ME: The epidemiology of migraine. Am J Med 2005, 118(suppl 1):3S-10S.
4. Stewart WF, Lipton RB, Celentano DD, Reed ML: Prevalence of migraine headache in the United States: relation to age, income, race, and other sociodemographic factors. JAMA 1992, 267:64-69.
5. Collaborative Group for the Study of Stroke in Young Women: Oral contraceptives and stroke in young women: associated risk factors. JAMA 1975, 231:718-722.
6. Henrich JB, Horwitz RI: A controlled study of ischemic stroke risk in migraine patients. J Clin Epidemiol 1989, 42:773-780.
7. Tzourio C, Iglesias S, Hubert JB, et al.: Migraine and risk of ischaemic stroke: a case-control study. Br Med J 1993, 307:289-292.
8. Tzourio C, Tehindrazanarivelo A, Iglesias S, et al.: Case-control study of migraine and risk of ischaemic stroke in young women. Br Med J 1995, 310:830-833.
9. Chang CL, Donaghy M, Poulter N: Migraine and stroke in young women: case-control study. The World Health Organisation Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. Br Med J 1999, 318:13-18.
10. Kurth T, Slomke MA, Kase CS, et al.: Migraine, headache, and the risk of stroke in women: a prospective study. Neurology 2005, 64:1020-1026.
11. Stang PE, Carson AP, Rose KM, et al.: Headache, cerebrovascular symptoms, and stroke: the Atherosclerosis Risk in Communities Study. Neurology 2005, 64:1573-1577.
12. Marini C, Carolei A, Roberts RS, et al.: Focal cerebral ischemia in young adults: a collaborative case-control study. The National Research Council Study Group. Neuroepidemiology 1993, 12:70-81.
13. Lidegaard O: Oral contraceptives, pregnancy, and the risk of cerebral thromboembolism: the influence of diabetes, hypertension, migraine, and previous thrombotic disease. Br J Obstet Gynaecol 1995, 102:153-159.
14. Carolei A, Marini C, De Matteis G. History of migraine and risk of cerebral ischaemia in young adults. The Italian National Research Council Study Group on Stroke in the Young. Lancet 1996, 347:1503-1506.
15. Haapaniemi H, Hillbom M, Juvela S: Lifestyle-associated risk factors for acute brain infarction among persons of working age. Stroke 1997, 28:26-30.
16. Donaghy M, Chang CL, Poulter N: Duration, frequency, recency, and type of migraine and the risk of ischaemic stroke in women of childbearing age. J Neurol Neurosurg Psychiatry 2002, 73:747-750.
17. Schwaag S, Nabavi DG, Frese A, et al.: The association between migraine and juvenile stroke: a case-control study. Headache 2003, 43:90-95.
18. Buring JE, Hebert P, Romero J, et al.: Migraine and subsequent risk of stroke in the Physicians' Health Study. Arch Neurol 1995, 52:129-134.
19. Nightingale AL, Farmer RD: Ischemic stroke in young women: a nested case-control study using the UK General Practice Research Database. Stroke 2004, 35:1574-1578.
20. Hall GC, Brown MM, Mo J, MacRae KD: Triptans in migraine: the risks of stroke, cardiovascular disease, and death in practice. Neurology 2004, 62:563-568.
21. Velentgas P, Cole JA, Mo J, et al.: Severe vascular events in migraine patients. Headache 2004, 44:642-651.
22. Merikangas KR, Fenton BT, Cheng SH, et al.: Association between migraine and stroke in a large-scale epidemiological study of the United States. Arch Neurol 1997, 54:362-368.
23. Kruit MC, van Buchem MA, Hofman PA, et al.: Migraine as a risk factor for subclinical brain lesions. JAMA 2004, 291:427-434.
24. Sochurkova D, Moreau T, Lemesle M, et al.: Migraine history and migraine-induced stroke in the Dijon stroke registry. Neuroepidemiology 1999, 18:85-91.
25. Milhaud D, Bogousslavsky J, van Melle G, Liot P: Ischemic stroke and active migraine. Neurology 2001, 57:1805-1811.
26. Etminan M, Takkouche B, Isorna FC, Samii A: Risk of ischaemic stroke in people with migraine: systematic review and meta-analysis of observational studies. Br Med J 2005, 330:63-65.
27. Leira R, Davalos A, Aneiros A, et al.: Headache as a surrogate marker of the molecular mechanisms implicated in progressing stroke. Cephalalgia 2002, 22:303-308.
28. Tentschert S, Wimmer R, Greisenegger S, et al.: Headache at stroke onset in 2196 patients with ischemic stroke or transient ischemic attack. Stroke 2005, 36:e1-e3.
29. Headache Classification Committee of the International Headache Society: Classification and diagnostic criteria for headache disorders cranial neuralgias and facial pain. Cephalalgia 1988, 8:1-96.
30. Welch KM, Levine SR: Migraine-related stroke in the context of the International Headache Society classification of head pain. Arch Neurol 1990, 47:458-4-62.
31. Headache Classification Committee of the International Headache Society: The International Classification of Headache Disorders, edn 2. Cephalalgia 2004, 24(suppl 1):9-160.
32. Welch KM, Cao Y, Aurora S, et al.: MRI of the occipital cortex, red nucleus, and substantia nigra during visual aura of migraine. Neurology 1998, 51:1465-1469.
33. Bousser MG, Welch KM: Relation between migraine and stroke. Lancet Neurol 2005, 4:533-542.
34. Friberg L, Olesen J, Lassen NA, et al.: Cerebral oxygen extraction, oxygen consumption, and regional cerebral blood flow during the aura phase of migraine. Stroke 1994, 25:974-979.
35. Cutrer FM, Sorensen AG, Weisskoff RM, et al.: Perfusion-weighted imaging defects during spontaneous migrainous aura. Ann Neurol 1998, 43:25-31.
36. Woods RP, Iacoboni M, Mazziotta JC: Bilateral spreading cerebral hypoperfusion during spontaneous migraine headache. N Engl J Med 1994, 331:1689-1692.
37. D'Anglejan-Chatillon J, Ribeiro V, Mas JL, et al.: Migraine: a risk factor for dissection of cervical arteries. Headache 1989, 29:560-561.
38. Tzourio C, Benslamia L, Guillon B, et al.: Migraine and the risk of cervical artery dissection: a case-control study. Neurology 2002, 59:435-437.
39. Pezzini A, Granella F, Grassi M, et al.: History of migraine and the risk of spontaneous cervical artery dissection. Cephalalgia 2005, 25:575-580.
40. Tietjen GE, Al-Qasmi MM, Athanas K, et al.: Increased von Willebrand factor in migraine. Neurology 2001, 57:334-336.
41. Soriani S, Borgna-Pignatti C, Trabetti E, et al.: Frequency of factor V Leiden in juvenile migraine with aura. Headache 1998, 38:779-781.
42. Hering-Hanit R, Friedman Z, Schlesinger I, Ellis M: Evidence for activation of the coagulation system in migraine with aura. Cephalalgia 2001, 21:137-139.
43. Ferrari MD, Odink J, Tapparelli C, et al.: Serotonin metabolism in migraine. Neurology 1989, 39:1239-1242.
44. Waeber C, Moskowitz MA: Migraine as an inflammatory disorder. Neurology 2005, 64:S9-S15.
45. Scher AI, Terwindt GM, Picavet HS, et al.: Cardiovascular risk factors and migraine: the GEM population-based study. Neurology 2005, 64:614-620.
46. Rosamond W: Are migraine and coronary heart disease associated? An epidemiologic review. Headache 2004, 44:S5-S12.
47. Anzola GP, Magoni M, Guindani M, et al.: Potential source of cerebral embolism in migraine with aura: a transcranial Doppler study. Neurology 1999, 52:1622-1625.
48. Del Sette M, Angeli S, Leandri M, et al.: Migraine with aura and right-to-left shunt on transcranial Doppler: a case-control study. Cerebrovasc Dis 1998, 8:327-330.
49. Schwerzmann M, Wiher S, Nedeltchev K, et al.: Percutaneous closure of patent foramen ovate reduces the frequency of migraine attacks. Neurology 2004, 62:1399-1401.
50. Wilmshurst PT, Nightingale S, Walsh KP, Morrison WL: Effect on migraine of closure of cardiac right-to-left shunts to prevent recurrence of decompression illness or stroke or for haemodynamic reasons. Lancet 2000, 356:1648-1651.
51. Wilmshurst PT, Pearson MJ, Nightingale S, et al.: Inheritance of persistent foramen ovate and atrial septal defects and the relation to familial migraine with aura. Heart 2004, 90:1315-1320.
52. Vahedi K, Chabriat H, Levy C, et al.: Migraine with aura and brain magnetic resonance imaging abnormalities in patients with CADASIL. Arch Neurol 2004, 61:1237-1240.
53. Pavlakis SG, Phillips PC, DiMauro S, et al.: Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes: a distinctive clinical syndrome. Ann Neurol 1984, 16:481-488.
54. Terwindt GM, Haan J, Ophoff RA, et al.: Clinical and genetic analysis of a large Dutch family with autosomal dominant vascular retinopathy, migraine, and Raynaud's phenomenon. Brain 1998, 121:303-316.
55. Ophoff RA, Terwindt GM, Vergouwe MN, et al.: Familial hemiplegic migraine and episodic ataxia type-2 are caused by mutations in the Ca2+ channel gene CACNL1A4. Cell 1996, 87:543-552.
56. Welch KM, Mathew NT, Stone P, et al.: Tolerability of sumatriptan: clinical trials and post-marketing experience. Cephalalgia 2000, 20:687-695.
57. Dodick DW, Martin VT, Smith T, Silberstein S: Cardiovascular tolerability and safety of triptans: a review of clinical data. Headache 2004, 44:S20-S30.
58. Martin VT, Goldstein JA: Evaluating the safety and tolerability profile of acute treatments for migraine. Am J Med 2005, 118(suppl 1):S36-S44.
59. Diener HC, Hartung E, Chrubasik J, et al.: A comparative study of acetylsalicyclic acid and metoprolol for the prophylactic treatment of migraine: a randomised, controlled, double-blind, parallel group phase III study. Cephalalgia 2001, 21:140-144.
60. Ridker PM, Cook NR, Lee IM, et al.: A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women. N Engl J Med 2005, 352:1293-1304.